This study revealed that LINC00847 was associated with prognosis and immune infiltration and confirmed that LINC00847 decreased the expression of the immunotherapy-related gene PD-L1, which might prove that LINC00847 is a potential new target for tumor immunotherapy. This evidence concerns the gene CD274 and neoplasm.